Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (796)	8/25/1999 7:50:00 PM
From: DanZ	Read Replies (2) \| Respond to of 5582

Mike, I agree that somebody has been playing with GUMM big time lately. Yesterday, ARCA put up an offer to sell 5000 shares against a bid size of only 100 shares. Somebody then immediately put in a bid 1/16 higher than the previous bid and got filled for 2500 shares. A few minutes later, ARCA pulled their offer. This is a classic trick to bring in sellers so you can buy. Even GNLN has been playing this game the past two days and has been loading up below 11. Rumors have been circulating recently about a big dental gum contract and a foreign nicotine gum contract. In addition, the first clinical study for Zicam has been in review at the NEJM for several months. If I'm not mistaken, the average review time is approaching, so maybe we will have their disposition soon. Any positive announcement on dental gum, nicotine gum, or the study could send the stock much higher in a short period of time. If I had to guess, I would say that some people are jockeying for position, and it looks like they are mostly on the buy side. Dan